NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN)‘s stock had its “market perform” rating restated by BMO Capital Markets in a research report issued to clients and investors on Friday. They currently have a C$11.25 price objective on the stock. BMO Capital Markets’ price target suggests a potential upside of 5.63% from the stock’s previous close.
A number of other equities research analysts have also issued reports on the stock. CIBC reaffirmed a “neutral” rating and set a C$11.75 target price on shares of NorthWest Health Prop Real Est Inv Trust in a report on Monday, September 24th. Royal Bank of Canada upped their target price on shares of NorthWest Health Prop Real Est Inv Trust from C$11.50 to C$12.00 and gave the stock a “sector perform” rating in a report on Tuesday, October 2nd.
Shares of TSE NWH.UN opened at C$10.65 on Friday. NorthWest Health Prop Real Est Inv Trust has a one year low of C$10.34 and a one year high of C$11.70.
NorthWest Healthcare Properties Real Estate Investment Trust is an open‐ended real estate investment trust (REIT). The Company’s objectives are to manage its investments to provide stable, sustainable and growing cash flows through investments in healthcare real estate across the globe; build a diversified, growth‐oriented global portfolio of healthcare properties based on an initial portfolio of investments in Australasia, Brazil, Germany and Canada; capitalize on internal growth and seek accretive healthcare real estate acquisition opportunities in its target international markets, with a focus on Australasia, Brazil, Germany and Canada; grow the value of its assets and maximize the long‐term value of its Trust Units through its management, and provide predictable and growing cash distributions per unit, on a tax‐efficient basis.
Featured Story: Swap
Receive News & Ratings for NorthWest Health Prop Real Est Inv Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NorthWest Health Prop Real Est Inv Trust and related companies with MarketBeat.com's FREE daily email newsletter.